The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
The role of elastography in non-alcoholic fatty liver disease
Antonio Liguori1, Maria E Ainora1, Laura Riccardi1, Nicoletta DE Matthaeis1, Fabrizio Pizzolante1, Antonio Gasbarrini12, Maria A Zocco12, Antonio Grieco12, Gianludovico Rapaccini12, Luca Miele32
Author information
1Department of Medical and Surgical Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Sacred Heart Catholic University, Rome, Italy.
2Department of Medicine and Translational Surgery, Sacred Heart Catholic University, Rome, Italy.
3Department of Medical and Surgical Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Sacred Heart Catholic University, Rome, Italy - luca.miele@unicatt.it.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its prevalence is even higher in patients with risk factors such as type 2 diabetes and obesity. Liver biopsy is the gold standard for diagnosis of non-alcoholic steatohepatitis (NASH), particularly for the assessment of fibrosis stage that is a key prognostic factor. Noninvasive methods for assessment of liver fibrosis are a huge need in contemporary hepatology in order to stratify patient's risk of advanced and progressive liver disease. In this perspective different imaging techniques have been developed in last decades and showed high performance in liver fibrosis evaluation. Strengths and weaknesses of all imaging methods are summarized in this review.